论文信息 - A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse - 字舞流文

A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse

U. Stervbo | N. Babel | R. Viebahn | T. Westhoff | S. Pfaender | J. Stumpf | C. Hugo | F. Seibert | T. Roch | T. Meister | M. Anft | A. Blazquez-Navarro | P. Zgoura | S. Skrzypczyk

[1] J. Izopet,et al. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients , 2021, The New England journal of medicine.

[2] D. Segev,et al. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series , 2021, Annals of Internal Medicine.

[3] P. Vitulo,et al. Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients , 2021, American Journal of Transplantation.

[4] C. Conrad,et al. Impaired Humoral and Cellular Immunity after SARS-CoV2 BNT162b2 (Tozinameran) Prime-Boost Vaccination in Kidney Transplant Recipients , 2021, medRxiv.

[5] C. Wanner,et al. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.